A L Børresen - Concepedia

Author

A L Børresen

Also Known As

A L Borresen, A L Børresen, A. L. BORRESEN, A. L. BØRRESEN, A. L. Børresen, A.-L. Borresen, A.-L. Börresen, A.-L. Børresen, A.L Børresen, A.L. Børresen

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Oslo Norwegian Cancer Society Icelandic Cancer Society Harvard University Press University of California, Los Angeles

About

A L Børresen is an author at University of Oslo specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1.5K
2	Public Health	5	5	204
3	Health Sciences	4	4	501
4	Cell Biology	3	3	167
5	Biochemistry	1	1	16

A L Børresen

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. A L Børresen, Eivind Hovig, Birgitte Smith‐Sørensen, Proceedings of the National Academy of Sciences Breast OncologyMolecular BiologyPathologyMolecular GeneticsDisease Gene Identification	1991	191
Screening for germ line TP53 mutations in breast cancer patients. A L Børresen, Tone Ikdahl Andersen, Judy E. Garber, PubMed Breast OncologyOncologyCancer PathologyCodon 245Breast Cancer Patients	1992	189
p53 abnormalities in different subtypes of human sarcomas. Åshild Andreassen, Eivind Hovig, R Holm, PubMed P53 AlterationsTumoral PathologyMalignant DiseaseMedicinePathology	1993	138
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor. Steinunn Thorlacius, A L Børresen, J E Eyfjörd PubMed Breast OncologyGeneticsPathologySomatic P53 MutationsTumor Biology	1993	121
p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer. David Ryberg, Elin H. Kure, S Lystad, PubMed GeneticsPathologyTumor BiologyLung TumorsP53 Mutations	1994	101
Loss of 3p or 11p alleles is associated with testicular cancer tumors Ragnhild A. Lothe, Sophie D. Fosså, Anna E. Stenwig, Genomics Tumor BiologyCancer PathologyMedicineGeneticsPathology	1989	99
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. T Frebourg, J Kassel, K T Lam, Proceedings of the National Academy of Sciences Germ-line MutationsCancer PathologyPathologyP53 ProteinCancer Biology	1992	97
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. R.S. Cornelis, M. van Vliet, C.B.J. Vos, PubMed Breast OncologyGeneticsPathologyP53 ProteinTumor Biology	1994	88
High‐Density Lipoprotein as Carrier for Amyloid‐related Protein SAA in Rabbit Serum Bjøŕn Skogen, A L Børresen, J. B. Natvig, Scandinavian Journal of Immunology	1979	81
Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Ethan M. Lange, A L Børresen, X Chen, PubMed	1995	79

Page 1